On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy

Huang, YJ; Chang, CS; Peng, YC; Yeh, HZ; Yang, SS

Yang, SS (reprint author), Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, 1650,Sect 4,Taiwan Blvd, Taichung 407, Taiwan.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017; 80 (6): 341

Abstract

Background: Hepatitis B e antigen (HBeAg) status is associated with clinical outcomes, and seroconversion of HBeAg is one of the treatment goals. In t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索